These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15877102)

  • 1. A comparative study of epiretinal membranes associated with Eales' disease: a clinicopathologic evaluation.
    Majji AB; Vemuganti GK; Shah VA; Singh S; Das T; Jalali S
    Eye (Lond); 2006 Jan; 20(1):46-54. PubMed ID: 15877102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease.
    Madhavan HN; Therese KL; Gunisha P; Jayanthi U; Biswas J
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):822-5. PubMed ID: 10711699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease.
    Perentes Y; Chan CC; Bovey E; Uffer S; Herbort CP
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):311-4. PubMed ID: 12022026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcomes for vitrectomy in Eales' disease.
    Shukla D; Kanungo S; Prasad NM; Kim R
    Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease.
    Srivastava P; Saxena S; Khanna VK; Kumar D; Nath R; Seth PK
    Indian J Ophthalmol; 2000 Dec; 48(4):307-9. PubMed ID: 11340890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
    Rajesh M; Sulochana KN; Coral K; Punitham R; Biswas J; Babu K; Ramakrishnan S
    Indian J Ophthalmol; 2004 Jun; 52(2):139-44. PubMed ID: 15283219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eales' disease--10 years experience with a rare disease].
    Stoffelns BM; Kramann C; Schoepfer K
    Klin Monbl Augenheilkd; 2009 Apr; 226(4):299-304. PubMed ID: 19384787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histological and immunohistological investigations in human epiretinal membranes].
    Dawczynski J; Janz S; Kasper M; Franke S; Königsdörffer E; Augsten R; Strobel J
    Klin Monbl Augenheilkd; 2006 Aug; 223(8):687-90. PubMed ID: 16927226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis.
    Kase S; Saito W; Ohno S; Ishida S
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5909-12. PubMed ID: 19516000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigations on the association of Mycobacterium tuberculosis with Eales' disease.
    Madhavan HN; Therese KL; Doraiswamy K
    Indian J Ophthalmol; 2002 Mar; 50(1):35-9. PubMed ID: 12090085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
    Swamy-Mruthinti S; Miriam KC; Kumar SK; Biswas J; Ramakrishnan S; Nagaraj RH; Sulochana KN
    Curr Eye Res; 2002 Sep; 25(3):139-45. PubMed ID: 12607183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous.
    Sulochana KN; Biswas J; Ramakrishnan S
    Curr Eye Res; 1999 Sep; 19(3):254-9. PubMed ID: 10487964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of a 88 kDa Eales protein in uveitis, tuberculosis, leprosy and rheumatoid arthritis.
    Rajesh M; Sulochana KN; Sundaram AL; Krishnakumar S; Biswas J; Ramakrishnan S
    Med Sci Monit; 2003 Feb; 9(2):CR95-9. PubMed ID: 12601295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of human leukocyte antigens in Eales' disease.
    Biswas J; Mukesh BN; Narain S; Roy S; Madhavan HN
    Int Ophthalmol; 1997-1998; 21(5):277-81. PubMed ID: 9756436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tearing and folding of the retinal internal limiting membrane associated with macular epiretinal membrane.
    Bovey EH; Uffer S
    Retina; 2008 Mar; 28(3):433-40. PubMed ID: 18327135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eales' disease: the great masquerader.
    Davis J; Schecter SH; Sowka J
    Optometry; 2009 Jul; 80(7):354-9. PubMed ID: 19545848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of mycobacteria with Eales' disease.
    Therese KL; Deepa P; Therese J; Bagyalakshmi R; Biswas J; Madhavan HN
    Indian J Med Res; 2007 Jul; 126(1):56-62. PubMed ID: 17890825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eales' disease with central nervous system infarction.
    Katz B; Wheeler D; Weinreb RN; Swenson MR
    Ann Ophthalmol; 1991 Dec; 23(12):460-3. PubMed ID: 1785904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined photocoagulation and cryotherapy in treatment of Eales' retinopathy. Preliminary report.
    Das T; Namperumalsamy P
    Indian J Ophthalmol; 1987; 35(5-6):108-18. PubMed ID: 3508757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.